Maria A. Grignano

Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Human Neutrophil Elastase and the Protein-Storm Axis: Reversible Synthetic Inhibitors in Inflammatory Disease.

Human Neutrophil Elastase and the Protein-Storm Axis: Reversible Synthetic Inhibitors in Inflammatory Disease.

Journal: Molecules (Basel, Switzerland)

Published: April 01, 2026

The Differential Redox Resilience of Alvelestat and Sivelestat: A Mechanistic Hypothesis for Inhibitor Performance Under Oxidative Stress.

The Differential Redox Resilience of Alvelestat and Sivelestat: A Mechanistic Hypothesis for Inhibitor Performance Under Oxidative Stress.

Journal: Molecules (Basel, Switzerland)

Published: March 24, 2026

Beyond Oral Anticoagulants Two Case Reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy.

Beyond Oral Anticoagulants Two Case Reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy.

Journal: Nephron

Published: October 13, 2025

MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?

MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?

Journal: European journal of internal medicine

Published: October 08, 2025

Cutaneous Alternariosis Caused by Alternaria infectoria: A Case Report in Kidney Transplant Recipient and Literature Review.

Cutaneous Alternariosis Caused by Alternaria infectoria: A Case Report in Kidney Transplant Recipient and Literature Review.

Journal: Journal of fungi (Basel, Switzerland)

Published: September 11, 2025

A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model.

A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model.

Journal: International journal of molecular sciences

Published: June 24, 2025

Case Report: Extracorporeal photopheresis for BK virus nephropathy as a novel treatment for high-risk rejection kidney transplant recipient.

Case Report: Extracorporeal photopheresis for BK virus nephropathy as a novel treatment for high-risk rejection kidney transplant recipient.

Journal: Frontiers in nephrology

Published: May 08, 2025

Can Proteomics Play a Significant Role in the Identification of Biomarkers for Alpha1-Antitrypsin Deficiency?

Can Proteomics Play a Significant Role in the Identification of Biomarkers for Alpha1-Antitrypsin Deficiency?

Journal: International journal of molecular sciences

Published: April 22, 2025

Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.

Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.

Journal: International journal of molecular sciences

Published: March 03, 2025

Pre-transplant IE1-specific T-cell response and CD8+ T-cell count as predictive markers of treated HCMV reactivation in kidney transplant recipients.

Pre-transplant IE1-specific T-cell response and CD8+ T-cell count as predictive markers of treated HCMV reactivation in kidney transplant recipients.

Journal: Frontiers in immunology

Published: December 03, 2024

Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review.

Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review.

Journal: Infectious disease reports

Published: September 16, 2024

Sputum proteomics in lung disorders.

Sputum proteomics in lung disorders.

Journal: Advances in clinical chemistry

Published: August 07, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026